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March 2009812 Abstractsassociated with adiposity. The study used data from patients in the European
Prospective Investigation into Cancer and Nutrition (EPIC). The associa-
tion of waist circumference, waist–hip ratio, and BMI was assessed for risk of
death among 359,387 participants in nine European countries. Age was
used as the time variable in a Cox regression analysis and was stratified
according to study center and age at recruitment. Further adjustments were
made for smoking status, alcohol consumption, height, physical activity, and
educational level.
During themean follow-up of 9.7 years, 14,723 participants died.With
respect to BMI, the lowest risk of death was observed at a BMI of 25.3 for
men and 24.3 for women. Adjusting for BMI, waist–hip ratio, and waist
circumference were strongly associated with risk of death. Relative risks
among men and women in the highest quintile of waist circumference were
2.05 (95% confidence interval [CI], 1.82-2.33), and 1.78 (95% CI, 1.56-
2.04), respectively. The waist–hip ratio relative risk for death for men in the
highest quintile was 1.68 (95% CI, 1.53-1.84) and for women was 1.51
(95% CI, 1.37-1.66).
Comment: Adipose tissue, especially adipose tissue associated with
visceral fat deposits, can secrete mediators that are likely important in the
development of chronic diseases. These mediators are thought to potentiate
inflammation that has been associated with respiratory ailments, cancer, and
atherosclerosis. Indeed, a recent report suggests the increased risk of death
associated with a high BMI is driven by cancer and cardiovascular causes
(N Engl J Med 2006;355:779-87). BMI, however, is not the whole story
when it comes to the effect of adipose tissue on life span. The study results
suggest that in patients with low BMI, measurements of waist circumference
or waist-to-hip ratio are more important predictors of the risk of death than
the BMI itself. The study also challenges the use of precise cutoff points to
define the risk of death associated with abdominal obesity. The risk imposed
by the presence of adipose tissue exists essentially as a continuous rather than
as a categoric variable, and it now appears important to assess distribution of
body fat even in persons of normal weight.
APredictiveModel for IdentifyingSurgical Patients atRisk ofMethicillin-
Resistant Staphylococcus Aureus Carriage on Admission
Harbarth S, Sax H, Uckay I, et al. J Am Coll Surg 2008;207:683-9.
Conclusions: Surgical patients recently treated with antibiotics, those
with recent hospitalizations, and those aged 75 years are at increased risk
of being carriers for methicillin resistant Staphylococcus aureus (MRSA) on
admission to the hospital.
Summary:There are guidelines for control of nosocomial transmission
of MRSA (Infect Control Hosp Epidemiol 203;24:362-86). The spread of
MRSA is facilitated by cross-transmission via health care workers’ hands and
broad-spectrum antibiotic treatment selecting for MRSA. MRSA infections
are associated with increased treatment cost and excess morbidity and
mortality. MRSA is now present in the community, and patients without
previous MRSA infection are being increasingly recognized on admission to
the hospital. The authors sought to develop and validate a prediction model
to confine surgical patients with previously unknownMRSAwho are, in fact,
carriers of MRSA on admission to the hospital. The authors used two
prospective studies to derive and validate predictors of previously unknown
MRSA carriage on admission. There were 13,262 patients (derivation
cohort, 3069; validation cohort, 10,193) admitted to the surgery depart-
ment of Geneva University Hospitals in Switzerland. MRSA carriage at the
time of admission increased from 3.2% in 2003 to 5.1% from 2004 to 2006.
Of the patients carrying MRSA, 64% were newly identified carriers. Logis-
tical regression analysis identified three independent factors correlated with
previously unknown MRSA carriage: (1) recent antibiotic treatment (ad-
justed odds ratio [OR], 4.5; P  .001), (2) history of hospitalization
(adjusted OR, 2.7; P .03), and (3) age75 years (adjusted OR, 1.9; P
.048). A score of 0 to 9 points was calculated for these variables. There were
152 patients with a score of 2 points, and previously unknown MRSA
carriage was 5% (n 8); 166 had an intermediate score of 3 to 6 points, and
previously unrecognized MRSA carriage was 11% (n  19); and 87 had a
score 7 points, and previously unrecognized MRSA carriage was 34%
(n  30).
Comment: These data indicate most MRSA carriers are unknown at
the time of hospital admission. The three variables found to be predictive of
unsuspected MRSA infection—previous hospitalization, recent antibiotic
use, and age 75 years—are extremely common in patients with vascular
disease admitted to the hospital. Vascular surgeons should be aware that
many of their patients without previously recognized MRSA infection are
very likely to be carriers of MRSA at the time of their admission to the
hospital.
Identifying Unprovoked Thromboembolism Patients at Low Risk for
Recurrence Who Can Discontinue Anticoagulant Therapy
Rodger MA, Kahn SR, Wells PS, et al. Can Med Assoc J 2008;179:417-26.Conclusion: Oral anticoagulation therapy can be safely discontinued
after 6 months in woman who have zero or one potential predictor of
recurrent venous thromboembolism (VTE).
Summary:Optimal duration of anticoagulation after unprovoked VTE
is controversial. In this study the authors sought to identify clinical predic-
tors to identify patients at low risk of VTE recurrence after discontinuation
of oral anticoagulants.
This was a multicenter prospective cohort study involving 646 patients
with a first unprovoked major VTE. Patients were enrolled during a 4-year
period, and 600 completed a mean 18-month follow-up. Data were col-
lected for 16 potential predictors of recurrent VTE during the time patients
were taking oral anticoagulation therapy (5 to 7 months after initiation).
After discontinuation of oral anticoagulation therapy, patients were moni-
tored for recurrent VTE.
During follow-up, 91 confirmed episodes of recurrent VTE were
identified (annual risk, 9.3%; 95% confidence interval [CI], 7.1%-11.3%).
The annual risk for men was 13.7% (95% CI, 10.8%-17.0%). No combina-
tion of clinical predictors could identify a low-risk subgroup of men. Zero or
one of the following characteristics were present in 52% of women: D-dimer
level 250 mg/L while taking warfarin; body mass index 30 kg/m2;
hyperpigmentation, edema, or redness of either leg; or age 65 years.
Women with zero or one of these predictors had an annual risk of VTE
recurrence of 1.6% (95% CI, 0.3%-4.6%). Women with two or more of these
predictors had an annual risk of VTE recurrence of 14.1% (95% CI, 10.9%-
17.3%).
Comment: This study is consistent with the previously determined
adverse effect of male sex on the recurrence of VTE (Lancet 2006;368:371-
8). There are three major points here. First, identification of risk factors after
5 to 7 months of oral anticoagulation therapy is a strong predictor of
recurrent VTE. Second, D-dimer levels after stopping oral anticoagulation
may not be sufficient to identify patients at low risk of recurrence, whereas
D-dimer levels while taking oral anticoagulationmay be a strong predictor of
recurrent VTE. The point is particularly interesting in that it allows more
efficient care of patients. Stopping anticoagulation and testing D-dimer
levels 1 month later and subsequently restarting anticoagulation therapy if
necessary is impractical and exposes potentially high-risk patients to a period
without anticoagulation. Finally, the authors identified a clinical decision
rule that identifies women at low risk of VTE.
Intermittent Claudication in Diabetes Mellitus Due to Chronic Exer-
tional Compartment Syndrome of the Leg: An Observational Study of
17 Patients
Edmundsson D, Svensson O, Toolanen G. Acta Orthop 2008;79:534-9.
Conclusion: Chronic exertional compartment syndrome (CECS) of
the leg can cause intermittent claudication in patients with diabetes. Fas-
ciotomy provides good results and increased pain-free walking time.
Summary: The authors investigated whether symptoms of claudica-
tion could occur in patients with diabetes as a result of chronic exertional
compartment syndrome (CECS). The report concerns 17 patients (3 men
and 14 women) with a mean age of 39 years (range 18-72 years). All had
diabetes mellitus and 12 had type I diabetes mellitus. All had leg pain during
walking, relieved at rest, and none had clinical signs of peripheral arterial
disease. The mean duration of diabetes was 22 years (range, 1-41 years), and
12 patients had peripheral neuropathy, retinopathy, or nephropathy. Leg
muscles were firm and tender on palpation.
Patients were evaluated with scintigraphy and intramuscular pressure
measurements during exercise. These evaluations resulted in 16 of 17
patients being diagnosed with CECS. Intramuscular compartment pressures
in leg compartments were higher in diabetic patients than in physically active
nondiabetic individuals without CECS (P  .05). The diagnosis of CECS
was made using the following criteria: history of exercised induced pain or
symptoms with reproduction of symptoms and pain during a treadmill
exercise test; or a combination of intramuscular pressures at rest 15 mm
Hg, an intramuscular pressure 30 mm Hg 1 to 2 minutes after the end of
the exercise test, or intramuscular pressure20 mmHg 5 minutes after the
end of the exercise test, all combined with reproduced leg pain. Recom-
mended treatment was fasciotomy of the anterior tibial and peroneal com-
partment using a 5-cm skin incision halfway between the fibular shaft and the
tibial crest in the middle portion of the leg. A 1-cm wide fascial strip was
removed during the procedure. Posterior compartments were treated with
fasciotomy of the superficial soleus and gastrocnemius muscles as well as the
deep posterior compartments.
Fifteen patients were treated with fasciotomy. At surgery the fascia was
observed to be thickened and “whitish,” and to have a “rubber-like”
consistency. After 1 year, 9 patients rated themselves excellent or good in 15
of the 18 treated compartments. Walking times until stopping on the
treadmill test increased after surgery from10 minutes to unlimited time in
8 of the 9 patients who underwent follow-up.
Comment: The authors’ small series suggests CECS may be a cause of
exercise induced leg pain in patients with diabetes. These patients likely
function at different levels than the traditional young athlete with CECS.
Nevertheless, the apparent dramatic increase in pain-free walking in the
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walking impairment, without evidence of peripheral vascular disease, should
be considered for a diagnosis of CECS. Fasciotomy in well-selected patients
appears to be efficacious.
Etiology and VTE Risk Factor Distribution in Patients with Inferior
Vena Cava Thrombosis
Linnemann B, Schmidt H, Schindewolf M, et al. Thromb Res 2008;123:
72-8.
Conclusions: In patients with deep venous thrombosis (DVT), local
abnormalities of the inferior vena cava (IVC), malignancy, and lupus anti-
coagulants are associated with increased risk of IVC thrombosis. IVC
thrombosis is associated with high risk of symptomatic pulmonary embolism
(PE) as well.
Summary: IVC thrombosis is relatively rare, and venous thromboem-
bolism risk factors that contribute to the development of IVC thrombosis
are not well characterized. The authors reviewed available cases of IVC
thrombosis registered in the MAISTHRO (Main-IS-ar-THROmbosis) da-
tabase. This registry enrolled 1770 consecutive patients with a documented
history of acute venous thromboembolism treated at university hospitals in
Frankfurt and Wurzburg, Germany. The authors identified 53 patients (35
males, 18 females) with IVC thrombosis between the ages of 12 to 79 yearsand selected as controls 265 patients with lower extremity DVTmatched for
age and gender from the MAISTHRO database. Diagnostic procedures for
PE were performed for clinical indications.
Of the 53 patients with IVC thrombosis, thrombosis developed in 40
(75.5%) before the age of 45. Local problems such as external venous
compression or IVC anomalies were identified in 22.6% as contributing to
the thrombosis. Lupus anticoagulants (10.9% vs 2.3%, P  .013) and
malignancy (17.0% vs 6.4%, P  .023) were more prevalent in the ICV
thrombosis patients vs the matched controls. No differences were found
between the IVC thrombosis patients and thematched controls for inherited
thrombophilias or other known VTE risk factors. Symptomatic PE occurred
in 32.1% of the IVC thrombosis patients and in 15.2% of the controls (P 
.005).
Comment: Although IVC thrombosis is a subset of DVT, it appears to
have slightly different predisposing factors compared with patients with
DVT isolated to the lower extremity. In particular, the study identified local
abnormalities of the vena cava, external compression of the vena cava from
neighboring pathologic processes, malignancy, and the presence of an-
tiphospholipid antibody syndrome as important predisposing factors to IVC
thrombosis. Patients with IVC thrombosis should therefore be investigated
for malignancy and the presence of antiphospholipid antibody syndrome.
The risk of symptomatic PE appears quite high. It may be reasonable to
consider the placement of a prophylactic vena cava filter.
